Pharmaceutical

FDA beats EMA to most approved new drugs in 2024

The FDA has narrowly beaten the European Medicines Agency (EMA) to the most approved drugs with a new active substance in 2024.

Jan 18, 2025 - 06:00
FDA beats EMA to most approved new drugs in 2024
The FDA has narrowly beaten the European Medicines Agency (EMA) to the most approved drugs with a new active substance in 2024.
Read the original article

Tags:

Previous Article

Charles River and Akron link to integrate cytokines into cell therapy

Next Article

COPD market to expand with AstraZeneca’s focus on biologics and strong portfolio...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Lyme disease cases rise, but largely due to a change in data collection

Lyme disease cases rise, but largely due to a change in...

Feb 15, 2024

Biden’s NIH nominee is languishing in Congress — alarming public health advocates

Biden’s NIH nominee is languishing in Congress — alarmi...

Jul 10, 2023

STAT+: Drug from Stoke shows lower activity against childhood epilepsy, prompting search for better dose

STAT+: Drug from Stoke shows lower activity against chi...

Jul 26, 2023